Xpovio combo bags FDA approval for refractory multiple myeloma

5th July 2019 Uncategorised 0

The application was also granted Fast Track designation, and Xpovio received Orphan Drug designation.

More: Xpovio combo bags FDA approval for refractory multiple myeloma
Source: News